You are here

Analysis

Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID --study

A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, is tied to a 61% reduction in COVID-19 hospitalization and a 58% lower rate of long COVID.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Research into why protective antibodies fade after COVID-19 vaccines --NIH

  • Researchers found that current COVID-19 vaccines fail to generate mature and durable antibody-producing cells in the bone marrow.
  • The findings could help explain why protection tends to decline over time.
  • Better understanding of long-term immune responses could lead to improved vaccines that provide enduring protection.
  • ...
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Flu season will make it harder to track the U.S. bird flu outbreak

...

with cold and flu season looming, it is likely to become significantly more difficult for the country’s public health departments to track the virus.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Analysis
howdy folks
Page loaded in 0.888 seconds.